Delcon 🤝 The Blood Center Great news! We recently sealed a partnership with The Blood Center – the primary supplier of blood, blood components, and plasma derivatives to local hospitals throughout South Louisiana and parts of the Mississippi Gulf Coast – for the supply of our Milano smart scales for blood collection. The devices will enable The Blood Center to make the work of blood collection operators safer and more efficient by digitalizing workflows and data collection 🩸 💬 “We are extremely excited and pleased to partner with Delcon USA, as we implement their Milano mixer/shaker and look forward to them positively enhancing our operational efficiencies,” said Billy Weales, President & CEO of The Blood Center. 📰 Read more about the partnership on AP News 👉 https://lnkd.in/d9bkACuV
Delcon’s Post
More Relevant Posts
-
Head of Endocrine Surgery Unit Osp. del Mare Napoli, Founder and Director of the SaveYourThyroid Project. Siumb General Secretary, Rome. Ad. Prof Turin University, Consultant at the SGH Cairo. DHA licensed.
“Non” thermal ablation of thyroid nodules! The clinical trial is going on, stay tuned for the “game changer” of the thyroid ablation. Always with the partenership of #SaveYourThyroid and #PulseBioSciences
-
-
Bianchini et al propose a combined stepwise technical approach where real time US can be used to select the best vascular access and, together with angiography, to manage the potential obstacles that may occur during transradial procedures https://lnkd.in/dDTSchDY Enrico Romagnoli
-
-
Have you ever wondered how your NIPT assay performs at critically low fetal fraction levels? Now you can find out thanks to our antepartum and postpartum reference materials which can be diluted to create various fetal fractions in order to assess your assay limit of detection (LoD) and complete a robust analytical validation. Find out more and order now at https://hubs.ly/Q02rJb9h0
-
Why does Prof. Dr. Sommer think that every patient deserves a map? * Determine ablation strategy based on the map * Assess ablation success & predict rist of recurrences * Reduce radiation exposure No matter if PFA, Cryo or RF TREAT AFIB YOUR WAY WITH A ONE SYSTEM SOLUTION. EnSite X. Because every patient deserves a map. What is your opinion? How do you do it and why? Safety Info: https://bit.ly/4buLEQy #Epeeps #AbbottProud #EP #EnsiteX #EPCentral #TeamNordNordWest Abbott The Corporate Village, Da Vincilaan 11 Box F1, 1935 Zaventem, Belgium, Tel: +32 2 774 68 11 cardiovascular.abbott Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use. ™ Indicates a trademark of the Abbott group of companies. © 2024 Abbott. All Rights Reserved. MAT-2406568 v1.0 | Item approved for EMEA use.
-
-
Have you ever wondered how your NIPT assay performs at critically low fetal fraction levels? Now you can find out thanks to our antepartum and postpartum reference materials which can be diluted to create various fetal fractions in order to assess your assay limit of detection (LoD) and complete a robust analytical validation. Find out more and order now at https://hubs.ly/Q02rJj8W0
Newest Solution: Seraseq® Antepartum & Postpartum cfDNA
digital.seracare.com
-
Glide to success with CEREGLIDE™ 71 with TruCourse™ Technology– the latest addition to the CERENOVUS Stroke Solutions™! This new catheter is informed by stroke science insights from our Neurothromboembolic Initiative (NTI) that includes robust research and clinical findings to seek and address unmet needs in #stroke: https://bit.ly/3HZmvk7
-
Noninvasive Substrate and Activation Mapping for Catheter Ablation of Ventricular Tachycardia: Are We There Yet? Savalan Babapoor, MD, and Chirag Barbhaiya, MD, present a case demonstrating the feasibility and potential usage of combined noninvasive substrate and activation mapping to facilitate catheter ablation of scar-related VT. https://okt.to/hZyxLF
Noninvasive Substrate and Activation Mapping for Catheter Ablation of Ventricular Tachycardia: Are We There Yet?
-
Inspection of the Hypopharynx and Larynx During EGD- an Endoscopic Atlas Watch: https://lnkd.in/eviC-xJj
-
-
Why does Prof. Dr. Sommer think that every patient deserves a map? * Determine ablation strategy based on the map * Assess ablation success & predict rist of recurrences * Reduce radiation exposure No matter if PFA, Cryo or RF TREAT AFIB YOUR WAY WITH A ONE SYSTEM SOLUTION. EnSite X. Because every patient deserves a map. What is your opinion? How do you do it and why? Safety Info: https://bit.ly/4buLEQy #TeamRuhrgebiet #Epeeps #AbbottProud #EP #EnsiteX Abbott The Corporate Village, Da Vincilaan 11 Box F1, 1935 Zaventem, Belgium, Tel: +32 2 774 68 11 cardiovascular.abbott Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use. ™ Indicates a trademark of the Abbott group of companies. © 2024 Abbott. All Rights Reserved. MAT-2406568 v1.0 | Item approved for EMEA use.
-
-
Experienced Research Advisor for Your Success / Italy Gen2Gen Business Resource Group Leader
Experience the future of multiplex IHC effortlessly!🔬 Elevate your research with our Invitrogen SuperBoost tyramide signal amplification kits, enhancing detection of low-abundance targets with unmatched precision. Dive deeper into cellular mysteries with advanced sensitivity - https://lnkd.in/duhscbK9 #Invitrogen #LabEfficiency #MultiplexIHC #SignalAmplification #SuperBoost
Economic Development Director, Lancaster County, South Carolina
3moCongratulations